Genta, Inc. (GNTA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA)

GNTA 2.300

+0.4%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob zagorin who wrote (1832)	6/2/2004 6:36:25 PM
From: Art Bechhoefer	Read Replies (1) of 1870

Bob, yes, ISIS is now testing its drugs (most of them, anyway) in combination with accepted chemo treatments. The reason seems to be that antisense drugs may or may not always work by themselves, but they tend to prevent the body from developing an allergic reaction to highly toxic chemo treatments, thereby prolonging the effectiveness of the chemo. Incidentally, I've been trying to get more info on the large sale of GNTA shares and have been trying for two days to speak to someone at Genta. Two days--and all I get are telephone answering machines. Either they are refusing to speak to anyone (including shareholders and investment advisors) or no one is there. In either case, this does not give me much confidence in the company and how they are handling their problems. There are at least eight class action suits that have been filed. If the company management tried to cover up certain facts about Genasense, then they could be in serious trouble, which could lead to a bankruptcy filing, with the shareholders losing everything. Art

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next